These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1840 related items for PubMed ID: 24818077

  • 1. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R, Tosun D, Ghosh P, Lehmann M, Madison CM, Weiner MW, Miller BL, Jagust WJ, Rabinovici GD.
    Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
    [Abstract] [Full Text] [Related]

  • 2. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.
    Ossenkoppele R, Schonhaut DR, Schöll M, Lockhart SN, Ayakta N, Baker SL, O'Neil JP, Janabi M, Lazaris A, Cantwell A, Vogel J, Santos M, Miller ZA, Bettcher BM, Vossel KA, Kramer JH, Gorno-Tempini ML, Miller BL, Jagust WJ, Rabinovici GD.
    Brain; 2016 May; 139(Pt 5):1551-67. PubMed ID: 26962052
    [Abstract] [Full Text] [Related]

  • 3. Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.
    Förster S, Yousefi BH, Wester HJ, Klupp E, Rominger A, Förstl H, Kurz A, Grimmer T, Drzezga A.
    Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1927-36. PubMed ID: 22926714
    [Abstract] [Full Text] [Related]

  • 4. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease.
    Lehmann M, Ghosh PM, Madison C, Laforce R, Corbetta-Rastelli C, Weiner MW, Greicius MD, Seeley WW, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust WJ, Rabinovici GD.
    Brain; 2013 Mar; 136(Pt 3):844-58. PubMed ID: 23358601
    [Abstract] [Full Text] [Related]

  • 5. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia.
    Rabinovici GD, Jagust WJ, Furst AJ, Ogar JM, Racine CA, Mormino EC, O'Neil JP, Lal RA, Dronkers NF, Miller BL, Gorno-Tempini ML.
    Ann Neurol; 2008 Oct; 64(4):388-401. PubMed ID: 18991338
    [Abstract] [Full Text] [Related]

  • 6. Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients.
    Lehmann M, Ghosh PM, Madison C, Karydas A, Coppola G, O'Neil JP, Huang Y, Miller BL, Jagust WJ, Rabinovici GD.
    J Neurol Neurosurg Psychiatry; 2014 Mar; 85(3):266-73. PubMed ID: 23965289
    [Abstract] [Full Text] [Related]

  • 7. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J, Lee SY, Kim SJ, Kim SH, Cho SJ, Kim YB.
    Neuroimage; 2010 Aug 15; 52(2):488-96. PubMed ID: 20385246
    [Abstract] [Full Text] [Related]

  • 8. Biopathological Significance of Early-Phase Amyloid Imaging in the Spectrum of Alzheimer's Disease.
    Bunai T, Kakimoto A, Yoshikawa E, Terada T, Ouchi Y.
    J Alzheimers Dis; 2019 Aug 15; 69(2):529-538. PubMed ID: 31104023
    [Abstract] [Full Text] [Related]

  • 9. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
    Knopman DS, Jack CR, Wiste HJ, Lundt ES, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Roberts RO, Boeve BF, Petersen RC.
    Neurobiol Aging; 2014 Sep 15; 35(9):2096-106. PubMed ID: 24702820
    [Abstract] [Full Text] [Related]

  • 10. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study.
    Edison P, Archer HA, Hinz R, Hammers A, Pavese N, Tai YF, Hotton G, Cutler D, Fox N, Kennedy A, Rossor M, Brooks DJ.
    Neurology; 2007 Feb 13; 68(7):501-8. PubMed ID: 17065593
    [Abstract] [Full Text] [Related]

  • 11. Diagnosed mild cognitive impairment due to Alzheimer's disease with PET biomarkers of beta amyloid and neuronal dysfunction.
    Hatashita S, Yamasaki H.
    PLoS One; 2013 Feb 13; 8(6):e66877. PubMed ID: 23799136
    [Abstract] [Full Text] [Related]

  • 12. Amyloid-β load predicts medial temporal lobe dysfunction in Alzheimer dementia.
    Frings L, Spehl TS, Weber WA, Hüll M, Meyer PT.
    J Nucl Med; 2013 Nov 13; 54(11):1909-14. PubMed ID: 24101684
    [Abstract] [Full Text] [Related]

  • 13. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, Långström B, Nordberg A.
    Brain; 2006 Nov 13; 129(Pt 11):2856-66. PubMed ID: 16854944
    [Abstract] [Full Text] [Related]

  • 14. Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease.
    Drzezga A, Grimmer T, Henriksen G, Stangier I, Perneczky R, Diehl-Schmid J, Mathis CA, Klunk WE, Price J, DeKosky S, Wester HJ, Schwaiger M, Kurz A.
    Neuroimage; 2008 Jan 15; 39(2):619-33. PubMed ID: 17962045
    [Abstract] [Full Text] [Related]

  • 15. Spatial Patterns of Hypometabolism and Amyloid Deposition in Variants of Alzheimer's Disease Corresponding to Brain Networks: a Prospective Cohort Study.
    Wang Y, Shi Z, Zhang N, Cai L, Li Y, Yang H, Yao S, Xing X, Ji Y, Gao S.
    Mol Imaging Biol; 2019 Feb 15; 21(1):140-148. PubMed ID: 29869063
    [Abstract] [Full Text] [Related]

  • 16. Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation.
    Racine AM, Adluru N, Alexander AL, Christian BT, Okonkwo OC, Oh J, Cleary CA, Birdsill A, Hillmer AT, Murali D, Barnhart TE, Gallagher CL, Carlsson CM, Rowley HA, Dowling NM, Asthana S, Sager MA, Bendlin BB, Johnson SC.
    Neuroimage Clin; 2014 Feb 15; 4():604-14. PubMed ID: 24936411
    [Abstract] [Full Text] [Related]

  • 17. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
    Oh H, Madison C, Baker S, Rabinovici G, Jagust W.
    Brain; 2016 Aug 15; 139(Pt 8):2275-89. PubMed ID: 27190008
    [Abstract] [Full Text] [Related]

  • 18. Clinical, Neuropsychological, and Neuroimaging Characteristics of Amyloid- positive vs. Amyloid-negative Patients with Clinically Diagnosed Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    Wang Y, Lou F, Li Y, Liu F, Wang Y, Cai L, Gordon ML, Zhang Y, Zhang N.
    Curr Alzheimer Res; 2021 Aug 15; 18(6):523-532. PubMed ID: 34598664
    [Abstract] [Full Text] [Related]

  • 19. Brain Network Alterations in Alzheimer's Disease Identified by Early-Phase PIB-PET.
    Fu L, Liu L, Zhang J, Xu B, Fan Y, Tian J.
    Contrast Media Mol Imaging; 2018 Aug 15; 2018():6830105. PubMed ID: 29531506
    [Abstract] [Full Text] [Related]

  • 20. The Behavioral/Dysexecutive Variant of Alzheimer's Disease: A Case Series with Clinical, Neuropsychological, and FDG-PET Characterization.
    Bergeron D, Sellami L, Poulin S, Verret L, Bouchard RW, Laforce R.
    Dement Geriatr Cogn Disord; 2020 Aug 15; 49(5):518-525. PubMed ID: 33207355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 92.